Khaled Kteily is a healthcare entrepreneur and the founder and CEO of Legacy, a healthcare company that works on male fertility services. After founding Legacy, Khaled has worked on the growth of a digital approach to fertility testing and preservation, planning to improve access to reproductive health services.
Khaled Kteily was born on January 12, 1989, in Montreal, Canada, and started his career in healthcare innovation and entrepreneurship. Before founding his own company, Legacy, he gained experience in healthcare consulting and business development, including working with organisations in the healthcare field. Khaled founded Legacy in 2018 as a company that works on male fertility. The company provides digital healthcare services related to fertility testing and sperm preservation, using technology to connect individuals with clinical services and laboratory-based examinations.
Read Also: Legacy Expands Access to Fertility Preservation Through Digital Services
Under his leadership, Legacy has emerged as a digital healthcare model that is designed to make male fertility services more accessible to individuals. The company has received attention within the healthcare technology field for its focus on fertility preservation and at-home testing options. Kteily has received his Master’s degree from Harvard University and undergraduate studies at McGill University. He has also been involved in discussions in healthcare innovation, entrepreneurship, and the future of reproductive health.
As an entrepreneur, Khaled Kteily has focused on addressing challenges in male fertility awareness and access to reproductive healthcare. His work with Legacy demonstrates substantial changes in digital health, where technology platforms are increasingly being used to deliver specialised healthcare services. Through Legacy, Khaled keeps on working in healthcare and technology and contributes to the growing conversation in fertility preservation and modern approaches to male reproductive health.